Physician profile
Krishna Patel
NPI 1265056063
$1,492.44
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,308 · 2022: $64.24 · 2023: $90.78 · 2024: $29.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $445.86 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $358.10 | 2021 | |
| Harmony Biosciences LLC | $318.84 | 2021-2022 | |
| Inspire Medical Systems, INC. | $134.29 | 2021 | |
| Abbvie INC. | $103.52 | 2022-2024 | |
| Eisai INC. | $52.05 | 2021 | |
| Rochester Medical Corporation | $26.46 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.62 | 2023 | Xifaxan |
| Neos Therapeutics, LP | $18.55 | 2021 | |
| Fresenius Kabi USA, LLC | $16.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.